NEWS

Michael Levitt & AIDEVI: Positive on NMN18000's Future in China

May 09,2024 | AIDEVI

Professor Michael Levitt, the 2013 Nobel laureate in Chemistry, was invited to become the chief scientific adviser for AIDEVI and discussed NMN18000's future plans in the Chinese market with the AIDEVI China team.

Healthy Aging

NMN may increase the ability to fight off free radicals and oxidative stress.

NMN is the ideal supplement that can make you look and feel young again by improving skin elasticity resulting in fewer wrinkles. New research published (June 2021) shows that NMN may protect and even reverse skin damage caused by UV rays. Research has also found that NAD+ stimulates the production of collagen.

NMN may also improve bone density, eye health, and insulin sensitivity, based on age-associated studies with mice.

DNA Repair & Metabolism

Increased NAD+ levels stimulate the activity of sirtuins which promote metabolism and the speedy breakdown of food into energy which may aid in weight management. Optimized NAD+ levels stimulating metabolic activity may also shorten recovery time and prolong youth by accelerating the repair of damaged DNA.

Emerging research from clinical trials also appears to show that increasing NAD+ levels improves insulin sensitivity, increases glucose tolerance, and may help make it easier to lose weight.

Enhanced Energy

Low NAD+ levels in the body result in feeling tired and lethargic. Supplementing with NMN increases energy giving you the needed boost to propel you through the day by reducing fatigue.

NAD+ optimizes energy production and efficiency in mitochondria restoring overall vitality. Peak performance athletes seeking increased muscle strength and endurance value NMN's ability to enhance their competitive edge naturally.

Harvard mice studies show that NMN optimizes the capacity of endothelial cells lining blood vessels resulting in 80% better exercise capacity. This may also enhance mobility for people who can no longer exercise because of frailty, disability, or old age.

NEWS

Michael Levitt & AIDEVI: Positive on NMN18000's Future in China